VCAM-1 has already shown promising utility as a predictive biomarker for CVD, and the significant associations between VACM-1 and CVDs like hypertension, atherosclerosis, ischaemic heart disease, stroke, heart failure, arrhythmias, and atrial fibrillation have been discussed previously (47). This evidence concerns the gene VCAM1 and atrial fibrillation.